Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis

Neurology
M E GurneyE D Hall

Abstract

Riluzole was tested in a dose-ranging study for preservation of motor function in a transgenic mouse model of familial ALS. The model is based on expression of mutant human Cu,Zn superoxide dismutase in mouse brain and spinal cord. In contrast with the human ALS trials, in the mouse model, riluzole significantly preserved motor function as assessed by nightly running in a wheel. The effect of riluzole on motor performance was greater earlier in disease than later, suggesting that riluzole may have benefit for "quality-of-life" measures in ALS. Treatment with riluzole was initiated earlier in the transgenic model than in the human ALS trials, which may account for the significantly better outcome.

References

Jan 3, 1991·The New England Journal of Medicine·N WeidnerJ Folkman

❮ Previous
Next ❯

Citations

Feb 23, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M E Gurney
Feb 24, 2001·Journal of Neurology·A C Ludolph
May 7, 2009·Neuromolecular Medicine·Daniel A BruestleMark P Mattson
Nov 21, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Swati Aggarwal, Merit Cudkowicz
Oct 26, 2001·Journal of the Neurological Sciences·M Tavakoli, M Malek
Mar 27, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Peter C Waldmeier
Feb 22, 2003·Biochimie·Janice RobertsonJean-Pierre Julien
Jan 12, 2002·Brain Research Bulletin·A E WillingP R Sanberg
Jul 24, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ghanashyam D GhadgeRaymond P Roos
Jul 26, 2012·Neurology Research International·Kalina Venkova-HristovaKenneth Hensley
Jun 21, 2011·PloS One·Jesse A SolomonMazen J Hamadeh
Dec 8, 2009·Neuropsychiatric Disease and Treatment·Stefano ZoccolellaPaolo Lamberti
Feb 27, 2014·The Journal of Clinical Investigation·Qiongman KongChien-Liang Glenn Lin
May 1, 2012·Clinical Investigation·James D Berry, Merit E Cudkowicz
Feb 9, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Maria C ObinuAssunta Imperato
Aug 14, 2008·CNS Drugs·Christopher PittengerGerard Sanacora
Mar 28, 2012·Expert Review of Neurotherapeutics·Bharath WootlaMoses Rodriguez
Mar 15, 2006·Expert Review of Neurotherapeutics·Lucie I Bruijn, Merit Cudkowicz
Jul 3, 2007·Expert Opinion on Emerging Drugs·Richard S BedlackMerit E Cudkowicz
Feb 15, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Sean ScottJames A Heywood
Mar 21, 2006·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Muriel ChritinGerard Besson
Nov 1, 2013·Drug Discovery Today·Bariş Genç, P Hande Özdinler
Nov 10, 2012·Physical Medicine and Rehabilitation Clinics of North America·Andrew J SkalskyDavid Richman
Mar 9, 2011·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Steve VucicMatthew C Kiernan
Mar 17, 2009·Experimental Neurology·Brett M MorrisonKathryn R Wagner
Jul 16, 2008·Physical Medicine and Rehabilitation Clinics of North America·B Jane DistadRobert G Miller
Dec 7, 2007·Journal of the Neurological Sciences·Chan-Il ChoiHaeyoung Suh-Kim
Sep 21, 2004·Journal of Neuroscience Research·Federica AlboCristina Zona
Sep 25, 2003·Muscle & Nerve·Hafedh HaddadJudith Melki
Nov 18, 2005·Journal of Clinical Pharmacology·Rabia B Choudry, Merit E Cudkowicz
Mar 9, 2007·Biotechnology Journal·Carsten W Lederer, Niovi Santama
May 13, 2006·Trends in Pharmacological Sciences·Maria Teresa CarrìCatrerina Bendotti

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.